You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萊美藥業(300006.SZ)擬定增募資不超10.84億元 中恆集團參與認購
格隆匯 07-03 21:04

格隆匯 7 月 3日丨萊美藥業(300006.SZ)披露向特定對象非公開發行股票預案,此次非公開發行股票募集資金總額為不超過約10.84億元(含此數),扣除發行費用後,募集資金淨額將用於償還借款及補充流動資金,其中7億元用於償還借款,剩餘部分用於補充流動資金。

此次非公開發行股票的發行價格為定價基準日前二十個交易日公司股票交易均價的百分之八十,即4.50元/股,符合《註冊辦法》的規定。根據2020年第二次臨時股東大會授權和2019年度權益分派結果,此次發行股票的發行價格由4.50元/股,調整為4.45元/股。

此次非公開發行股票的數量為不超過2.4367億股(含此數),3名特定發行對象已與公司簽署《附條件生效的股份認購合同》及其補充協議,全部以現金認購。此次非公開發行的具體認購情況如下:

中恆集團、中恆同德、廣投國宏認購的此次非公開發行的股票,均自發行結束之日起36個月內不得轉讓。

公司原實際控制人邱宇已與中恆集團簽署《表決權委託協議》,中恆集團成為公司單一擁有表決權份額最大的股東。通過認購此次非公開發行的股份,中恆集團直接持有和擁有表決權的股份數量以及中恆同德、廣投國宏持有的公司股份數量合計佔公司總股本(發行後)的比例將超過30%。此次非公開發行不會導致公司股權分佈不具備上市條件。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account